Cite
Fischer K, Tognarelli S, Roesler S, et al. The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells. Front Immunol. 2017;8:202doi: 10.3389/fimmu.2017.00202.
Fischer, K., Tognarelli, S., Roesler, S., Boedicker, C., Schubert, R., Steinle, A., Klingebiel, T., Bader, P., Fulda, S., & Ullrich, E. (2017). The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells. Frontiers in immunology, 8202. https://doi.org/10.3389/fimmu.2017.00202
Fischer, Kyra, et al. "The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells." Frontiers in immunology vol. 8 (2017): 202. doi: https://doi.org/10.3389/fimmu.2017.00202
Fischer K, Tognarelli S, Roesler S, Boedicker C, Schubert R, Steinle A, Klingebiel T, Bader P, Fulda S, Ullrich E. The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells. Front Immunol. 2017 Mar 07;8:202. doi: 10.3389/fimmu.2017.00202. eCollection 2017. PMID: 28326081; PMCID: PMC5339542.
Copy
Download .nbib